Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L.
G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3.
Comprehensive review of chromophobe renal cell carcinoma.
Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L.
Crit Rev Oncol Hematol. 2021 Apr;160:103287. doi: 10.1016/j.critrevonc.2021.103287. Epub 2021 Mar 19.
Renal Cell Carcinoma of Variant Histology: Biology and Therapies.
Msaouel P, Genovese G, Tannir NM.
Hematol Oncol Clin North Am. 2023 Oct;37(5):977-992. doi: 10.1016/j.hoc.2023.04.019. Epub 2023 May 25.
Metabolic reprogramming in clear cell renal cell carcinoma.
Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH.
Nat Rev Nephrol. 2017 Jul;13(7):410-419. doi: 10.1038/nrneph.2017.59. Epub 2017 May 8.
Clear Cell Renal Cell Carcinoma: A Comprehensive Review of its Histopathology, Genetics, and Differential Diagnosis.
Nezami BG, MacLennan GT.
Int J Surg Pathol. 2025 Apr;33(2):265-280. doi: 10.1177/10668969241256111. Epub 2024 Jul 25.
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM, Ricketts CJ.
Nat Rev Urol. 2019 Sep;16(9):539-552. doi: 10.1038/s41585-019-0211-5. Epub 2019 Jul 5.
Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney.
Akhtar M, Al-Bozom IA, Al Hussain T.
Adv Anat Pathol. 2018 May;25(3):189-196. doi: 10.1097/PAP.0000000000000185.
Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes.
Yang L, Wang X, Liu J, Liu X, Li S, Zheng F, Dong Q, Xu S, Xiong J, Fu B.
Front Immunol. 2023 Aug 11;14:1225023. doi: 10.3389/fimmu.2023.1225023. eCollection 2023.
Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.
Saout JR, Lecuyer G, Léonard S, Evrard B, Kammerer-Jacquet SF, Noël L, Khene ZE, Mathieu R, Brunot A, Rolland AD, Bensalah K, Rioux-Leclercq N, Lardenois A, Chalmel F.
Eur Urol. 2023 May;83(5):441-451. doi: 10.1016/j.eururo.2023.02.008. Epub 2023 Feb 15.
Patient-derived renal cell carcinoma organoids for personalized cancer therapy.
Li Z, Xu H, Yu L, Wang J, Meng Q, Mei H, Cai Z, Chen W, Huang W.
Clin Transl Med. 2022 Jul;12(7):e970. doi: 10.1002/ctm2.970.
